Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study

Vahab Fatourechi, Jaroslaw P. Aniszewski, Guiti Z.Eghbali Fatourechi, Elizabeth J. Atkinson, Steven J. Jacobsen

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

Subacute thyroiditis (SAT), or granulomatous thyroiditis, is an inflammatory thyroid condition associated with pain and systemic symptoms. Few community studies are available. We studied the 160 patients with SAT in Olmsted County, Minnesota, seen between January 1, 1960, and December 30, 1997. Subjects were identified through the medical diagnostic index of the Rochester Epidemiology Project. The overall age- and sex-adjusted incidence from 1960 through 1997 was 4.9 cases per 100,000/yr. In the most recent 28-yr period (1970-1997), 94 patients were identified. In this group, pain was the presenting symptom in 96%. SAT recurred in 4% of the patients 6-21 yr after the initial episode. Corticosteroid therapy was given to 36%. Early-onset hypothyroidism occurred both in patients receiving corticosteroid therapy (29%) and in those not receiving corticosteroid therapy (37%). At latest follow-up, significantly more patients who had received corticosteroid therapy had a diagnosis of hypothyroidism than the group without corticosteroid therapy (25% vs. 10%, P < 0.05; overall rate of hypothyroidism, 15%). Early transient hypothyroidism is common in SAT. Permanent hypothyroidism is less common, and only 15% of the patients are receiving T4 therapy after 28 yr of follow-up. Symptomatic relief is achieved with corticosteroid therapy, but such therapy does not prevent early- and late-onset thyroid dysfunction.

Original languageEnglish (US)
Pages (from-to)2100-2105
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume88
Issue number5
DOIs
StatePublished - May 1 2003

Fingerprint

Subacute Thyroiditis
Adrenal Cortex Hormones
Hypothyroidism
Incidence
Therapeutics
Epidemiology
Thyroid Gland
Pain

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Clinical features and outcome of subacute thyroiditis in an incidence cohort : Olmsted County, Minnesota, study. / Fatourechi, Vahab; Aniszewski, Jaroslaw P.; Fatourechi, Guiti Z.Eghbali; Atkinson, Elizabeth J.; Jacobsen, Steven J.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 88, No. 5, 01.05.2003, p. 2100-2105.

Research output: Contribution to journalArticle

Fatourechi, Vahab ; Aniszewski, Jaroslaw P. ; Fatourechi, Guiti Z.Eghbali ; Atkinson, Elizabeth J. ; Jacobsen, Steven J. / Clinical features and outcome of subacute thyroiditis in an incidence cohort : Olmsted County, Minnesota, study. In: Journal of Clinical Endocrinology and Metabolism. 2003 ; Vol. 88, No. 5. pp. 2100-2105.
@article{404c2e78c1c141e18ee51457141fe913,
title = "Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study",
abstract = "Subacute thyroiditis (SAT), or granulomatous thyroiditis, is an inflammatory thyroid condition associated with pain and systemic symptoms. Few community studies are available. We studied the 160 patients with SAT in Olmsted County, Minnesota, seen between January 1, 1960, and December 30, 1997. Subjects were identified through the medical diagnostic index of the Rochester Epidemiology Project. The overall age- and sex-adjusted incidence from 1960 through 1997 was 4.9 cases per 100,000/yr. In the most recent 28-yr period (1970-1997), 94 patients were identified. In this group, pain was the presenting symptom in 96{\%}. SAT recurred in 4{\%} of the patients 6-21 yr after the initial episode. Corticosteroid therapy was given to 36{\%}. Early-onset hypothyroidism occurred both in patients receiving corticosteroid therapy (29{\%}) and in those not receiving corticosteroid therapy (37{\%}). At latest follow-up, significantly more patients who had received corticosteroid therapy had a diagnosis of hypothyroidism than the group without corticosteroid therapy (25{\%} vs. 10{\%}, P < 0.05; overall rate of hypothyroidism, 15{\%}). Early transient hypothyroidism is common in SAT. Permanent hypothyroidism is less common, and only 15{\%} of the patients are receiving T4 therapy after 28 yr of follow-up. Symptomatic relief is achieved with corticosteroid therapy, but such therapy does not prevent early- and late-onset thyroid dysfunction.",
author = "Vahab Fatourechi and Aniszewski, {Jaroslaw P.} and Fatourechi, {Guiti Z.Eghbali} and Atkinson, {Elizabeth J.} and Jacobsen, {Steven J.}",
year = "2003",
month = "5",
day = "1",
doi = "10.1210/jc.2002-021799",
language = "English (US)",
volume = "88",
pages = "2100--2105",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Clinical features and outcome of subacute thyroiditis in an incidence cohort

T2 - Olmsted County, Minnesota, study

AU - Fatourechi, Vahab

AU - Aniszewski, Jaroslaw P.

AU - Fatourechi, Guiti Z.Eghbali

AU - Atkinson, Elizabeth J.

AU - Jacobsen, Steven J.

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Subacute thyroiditis (SAT), or granulomatous thyroiditis, is an inflammatory thyroid condition associated with pain and systemic symptoms. Few community studies are available. We studied the 160 patients with SAT in Olmsted County, Minnesota, seen between January 1, 1960, and December 30, 1997. Subjects were identified through the medical diagnostic index of the Rochester Epidemiology Project. The overall age- and sex-adjusted incidence from 1960 through 1997 was 4.9 cases per 100,000/yr. In the most recent 28-yr period (1970-1997), 94 patients were identified. In this group, pain was the presenting symptom in 96%. SAT recurred in 4% of the patients 6-21 yr after the initial episode. Corticosteroid therapy was given to 36%. Early-onset hypothyroidism occurred both in patients receiving corticosteroid therapy (29%) and in those not receiving corticosteroid therapy (37%). At latest follow-up, significantly more patients who had received corticosteroid therapy had a diagnosis of hypothyroidism than the group without corticosteroid therapy (25% vs. 10%, P < 0.05; overall rate of hypothyroidism, 15%). Early transient hypothyroidism is common in SAT. Permanent hypothyroidism is less common, and only 15% of the patients are receiving T4 therapy after 28 yr of follow-up. Symptomatic relief is achieved with corticosteroid therapy, but such therapy does not prevent early- and late-onset thyroid dysfunction.

AB - Subacute thyroiditis (SAT), or granulomatous thyroiditis, is an inflammatory thyroid condition associated with pain and systemic symptoms. Few community studies are available. We studied the 160 patients with SAT in Olmsted County, Minnesota, seen between January 1, 1960, and December 30, 1997. Subjects were identified through the medical diagnostic index of the Rochester Epidemiology Project. The overall age- and sex-adjusted incidence from 1960 through 1997 was 4.9 cases per 100,000/yr. In the most recent 28-yr period (1970-1997), 94 patients were identified. In this group, pain was the presenting symptom in 96%. SAT recurred in 4% of the patients 6-21 yr after the initial episode. Corticosteroid therapy was given to 36%. Early-onset hypothyroidism occurred both in patients receiving corticosteroid therapy (29%) and in those not receiving corticosteroid therapy (37%). At latest follow-up, significantly more patients who had received corticosteroid therapy had a diagnosis of hypothyroidism than the group without corticosteroid therapy (25% vs. 10%, P < 0.05; overall rate of hypothyroidism, 15%). Early transient hypothyroidism is common in SAT. Permanent hypothyroidism is less common, and only 15% of the patients are receiving T4 therapy after 28 yr of follow-up. Symptomatic relief is achieved with corticosteroid therapy, but such therapy does not prevent early- and late-onset thyroid dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=0038369005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038369005&partnerID=8YFLogxK

U2 - 10.1210/jc.2002-021799

DO - 10.1210/jc.2002-021799

M3 - Article

C2 - 12727961

AN - SCOPUS:0038369005

VL - 88

SP - 2100

EP - 2105

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -